antibioticsbooks

Index 295
Aribinosyl transferase III, 163
Arrhythmias, 98, 262, 274
Arteminsins, 258
Arthralgia, 98, 126, 162
Ascaris, 5, 258
A. lumbricoides, 269
Aspergillosis, 20, 185, 187,
189, 191
Aspergillus, 5, 167, 193, 198
aspergillosis, 20, 185, 187,
189, 191
A. terreus, 172
polyenes and, 172
voriconazole, 20
voriconazole and, 189
Asthma, 216, 274
Atazanavir (ATZ), 26, 223
described, 229–233
Atovaquone
described, 265–267
proguanil, 265–267
Atripla, 225, 228
Atypical bacteria, 4
Atypical mycobacterial
infections, 111
Atypicals, 102, 106
Avoidance of antibiotic use, 44
Azithromycin, 20
described, 109–112
Azoles, 171, 197. See also
individual drugs
antifungals, 31
introduction to, 179
Aztreonam, 49
described, 91–92
B
Babesia, 265
Bacillus, 9
Bacteremia, 131, 143
Bacteria, microbiology of, 3–14
Bactericidal drugs, bacteriostatic
versus, 37–38
Bacteriostatic drugs
versus bactericidal drugs,
37–38
macrolides, 109–112
Bartonella, 13
Benzathine, 54
Benzimidazoles, described,
269–271
Benzodiazepines, 232
b-hemolysis, 9
Beta-lactamases
beta-lactam/beta-lactamase
inhibitor combinations,
65–68
cephalosporins and, 70, 73
extended-spectrum (ESBL),
66, 87, 89
inhibitors, 52, 64, 75
penicillins and, 57–59, 63,
65–68, 70
Beta-lactams, 30, 39, 41, 42, 87,
100, 111, 121, 129, 137, 139,
149. See also individual
drugs
aminoglycosides and, 101,
102, 104
beta-lactamase inhibitor
combinations, 65–68
introduction to, 49–50
MSSA and, 58
seizures and, 49–50, 88–89
Staphylococci and, 50, 58, 96
B. fragilis group, 12, 75, 118,
137, 145
Bioavailability, 212
for antibiotics, 24, 25
of fluoroquinolones, 99
Birth defects, ribavirin, 250
Bladder infections, 30
Blastomyces, 5, 167
Bleeding, 74
Blood, concentration of antibiotic
in, 27
Blood pressure, 263
Boceprevir, 245–248
Bone marrow suppression, 114,
115, 134, 176, 222
Bone marrow transplant, 20
Bowel decontamination, 143
Bowel inflammation, 43
Breakpoints
defined, 34
examples of, 35–36
Broader-spectrum agent, 45
Broader-spectrum azole, 185–187